Catalyst Pharmaceuticals (CPRX) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.74% |
| Dec 31, 2025 | 38.39% |
| Sep 30, 2025 | -54.50% |
| Jun 30, 2025 | 18.74% |
| Mar 31, 2025 | -15.29% |
| Dec 31, 2024 | -2.74% |
| Sep 30, 2024 | 13.62% |
| Jun 30, 2024 | 100.89% |
| Mar 31, 2024 | -42.63% |
| Dec 31, 2023 | 23.31% |
| Sep 30, 2023 | 46.74% |
| Jun 30, 2023 | 154.80% |
| Mar 31, 2023 | -69.88% |
| Dec 31, 2022 | -2.96% |
| Sep 30, 2022 | 57.69% |
| Jun 30, 2022 | 208.93% |
| Mar 31, 2022 | -55.79% |
| Dec 31, 2021 | -11.66% |
| Sep 30, 2021 | 38.48% |
| Jun 30, 2021 | 310.99% |
| Mar 31, 2021 | -70.90% |
| Dec 31, 2020 | 14.44% |
| Sep 30, 2020 | -13.68% |
| Jun 30, 2020 | 83.90% |
| Mar 31, 2020 | -41.32% |
| Dec 31, 2019 | -24.42% |
| Sep 30, 2019 | 15.55% |
| Jun 30, 2019 | 275.56% |
| Mar 31, 2019 | 4.01% |
| Dec 31, 2018 | -20.12% |
| Sep 30, 2018 | -46.02% |
| Jun 30, 2018 | 21.70% |
| Mar 31, 2018 | -50.91% |
| Dec 31, 2017 | -53.06% |
| Sep 30, 2017 | 17.75% |
| Jun 30, 2017 | 17.48% |
| Mar 31, 2017 | 12.08% |
| Dec 31, 2016 | -34.59% |
| Sep 30, 2016 | 24.53% |
| Jun 30, 2016 | 26.76% |
| Mar 31, 2016 | -28.05% |
| Dec 31, 2015 | 13.32% |
| Sep 30, 2015 | -25.85% |
| Jun 30, 2015 | -11.88% |
| Mar 31, 2015 | 4.65% |
| Dec 31, 2014 | -12.02% |
| Sep 30, 2014 | -19.07% |
| Jun 30, 2014 | -23.04% |
| Mar 31, 2014 | 41.29% |
| Dec 31, 2013 | -145.27% |
| Sep 30, 2013 | 7.08% |
| Jun 30, 2013 | 19.43% |
| Mar 31, 2013 | -41.12% |
| Dec 31, 2012 | -44.77% |
| Sep 30, 2012 | 3.79% |
| Jun 30, 2012 | 12.06% |
| Mar 31, 2012 | 9.52% |
| Dec 31, 2011 | -14.81% |
| Sep 30, 2011 | 14.38% |
| Jun 30, 2011 | -76.04% |
| Mar 31, 2011 | -8.06% |
| Dec 31, 2010 | 5.90% |